Bernie Wooden’s story is hardly unique. The prostate-specific antigen (PSA) test used to be given to men fairy routinely. And men around the country—and the world—believe they’re alive today because their doctors noticed a sudden increase in their PSA levels. But in 2012, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against doing… Continue reading Should You Be Screened for Prostate Cancer?
Tag: Prostate Conditions
Drug-Like “Compounds” May Improve Prostate-Cancer Treatment
Researchers from Southern Methodist University have discovered three new compounds that could, ultimately, offer better survival odds to prostate cancer patients. The drug-like compounds can be modified and developed into medicines that target a protein in the human body that is responsible for chemotherapy resistance in cancers, said biochemist Pia D. Vogel, lead author on… Continue reading Drug-Like “Compounds” May Improve Prostate-Cancer Treatment
ED Worsened by Some Treatments of Prostate Enlargement
Men with benign prostate enlargement who used finasteride (also known as proscar and propecia) to treat their condition experienced worsening erectile dysfunction (ED) that did not resolve with continued treatment, according to research done at Boston University Medical Center. In addition, they experienced a reduction in their testosterone levels leading to hypogonadism (little to no… Continue reading ED Worsened by Some Treatments of Prostate Enlargement
Fee-for-Service Health Care Jeopardizes Robotic Prostate Surgery Patients
A “perverse disincentive” for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, according to a study led by Henry Ford Hospital researchers in Detroit and presented at the 2015 American Urological Association Annual Meeting in New Orleans. A release from the hospital… Continue reading Fee-for-Service Health Care Jeopardizes Robotic Prostate Surgery Patients
Review Upends Belief on Radiation after Prostate Cancer Surgery
Important news for men receiving treatment for prostate cancer: Two new studies from the University of Virginia School of Medicine have upended the widely held view that it’s best to delay radiation treatment as long as possible after the removal of the prostate in order to prevent unwanted side effects. A release from the university… Continue reading Review Upends Belief on Radiation after Prostate Cancer Surgery
Prostate Cancer And A Deadly Protein
Researchers have discovered that a newly discovered protein promotes prostate-cancer cell growth – and the finding could lead to a new therapeutic target for the illness. The findings from Keck School of Medicine, of the University of Southern California, provide evidence that the newly discovered member of a family of cell surface proteins called G-protein… Continue reading Prostate Cancer And A Deadly Protein
Prostate-Cancer Treatment Can be Fatal In Less Serious Cases
Androgen deprivation therapy (ADT), a common treatment for advanced prostate cancer, has been linked with increased risk of death in men with localized cancer and longer life expectancies, according researchers at Henry Ford Hospital. In ADT, an injectable or implanted medication is used to disrupt the body’s ability to make testosterone. In patients with advanced… Continue reading Prostate-Cancer Treatment Can be Fatal In Less Serious Cases
Many Men Aren’t Following Guidelines for PSA Screening
Although medical experts have issued guidelines recommending against the routine screening of elderly men for prostate cancer, the effect of the recommendations has been “minimal at best,” according to a new study. Many men still appear to be undergoing the screening. The study, by researchers from Henry Ford Hospital, was published as a research letter… Continue reading Many Men Aren’t Following Guidelines for PSA Screening
Tailor Made Prostate Treatment
Sequencing RNA (ribonucleic acid), not just DNA (deoxyribonucleic acid), could help doctors predict how prostate cancer tumors will respond to treatment, according to research published in August 2014 the open access journal Genome Biology. Because a tumor’s RNA shows the real time changes a treatment is causing, the authors think this could be a useful tool to aid diagnosis and predict which treatment will most benefit individual cancer patients.
Prostate Cancer Risk Calculator Online
A free updated calculator to help men and their doctors assess their risk of prostate cancer is available online. Developed at the University of Texas Health Science Center, the tool has had a major upgrade in order to enhance how men and their physicians better understand a man’s risk of prostate cancer. A description of the update’s needs and benefits is described by the Health Science Center authors in a viewpoint published online August 4th in the Journal of the American Medical Association.
Prostate-Cancer Radiation Has Some Dangers
Prostate-cancer patients who have received radiation treatment appear more likely to develop bladder or rectal cancer, new research shows. And while the number of cases is relatively low, investigators said that patients should still be monitored for those illnesses.
“Overall the incidence of these cancers is low. But when men have received radiation treatments, it’s important to evaluate carefully any symptoms that could be a sign of bladder or rectal cancer,” says senior study author Kathleen A.
Which Prostate Surgery Is Better?
Robotic surgery, the primary choice for removing cancerous prostate glands, is as safe as open surgery for Medicare patients over 65, according to a new survey.
The findings came in a survey that included analysis by researchers from Henry Ford Hospital. The hospital is a pioneer in robot-assisted radical prostatectomy (RARP), a minimally invasive procedure.
“Although studies comparing the two techniques were done early in the robotic era for this surgery, RARP boomed in more recent years, overtaking open surgery,” says study co-author Jesse D.
Low Risk Prostate Ca Not Always Low Risk
The criteria for active surveillance — often called “watch and wait” — in dealing with prostate cancer should be re-evaluated. That is the recommendation of a study done at the University of California, Los Angeles and published in the May 19th 2014 issue of the peer-reviewed Journal of Urology.
Aggressive Tx for Older Prostate Patients a Mistake
Treating older men with early-stage prostate cancer who also have other serious underlying health problems with aggressive therapies such as surgery or radiation therapy does not help them live longer and, in fact, can be detrimental, according to a study done by researchers at the University of California, Los Angeles. The study was published in the May 13th 2014 early online edition of the peer-reviewed journal Cancer.
Vitamin D and Aggressive Prostate Cancer
Researchers say that Vitamin D deficiency is an indicator of aggressive prostate cancer risk in middle-aged men who underwent a biopsy.
Adam B. Murphy, M.D., MBA, assistant professor in the Department of Urology at the Northwestern University Feinberg School of Medicine, said that the finding affected European-American and African-American men, although the link between Vitamin D deficiency andaggressive prostate cancer was stronger in African-Americans.
Inflammation Means Higher Risk for Prostate Cancer
Men who have chronic inflammation of prostate tissue appear to have nearly twice the risk of getting prostate cancer than do those with no inflammation, according to a new study from Johns Hopkins.
The link between persistent inflammation and cancer was especially strong for men with aggressive cases of the disease.
A Better Test For Prostate Cancer
Researchers have developed a painless method to test for prostate cancer, and that could help millions of men avoid a grueling diagnostic exam.
If a blood test turns up signs of prostate cancer, physicians usually remove samples of tissue through the anus, using 12 large biopsy needles. The procedure has been called “barbaric.”
That technique could be replaced thanks to researchers at Eindhoven University of Technology (TU/e), together with AMC Amsterdam. Research team leader Massimo Mischi at TU/e said the new procedure uses existing ultrasound scanners.
Androgen Deprivation Therapy Ineffective For Early-Stage Prostate Cancer
Men who got androgen deprivation therapy as the primary treatment in the early stages of prostate cancer didn’t live any longer than those who got no treatment at all, a study shows.
The researchers say that this conclusion, along with the risk of serious side effects such as heart disease and diabetes, “mitigates against any clinical or policy rationale for use of primary androgen deprivation therapy [PADT] in these men.”